ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Cognitive Therapy for Suicidal Older Men in Primary Care Settings

This study is currently recruiting participants.
Study NCT00149773.   Last updated on January 29, 2008.   Information provided by National Institute of Mental Health (NIMH)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Cognitive Therapy for Suicidal Older Men in Primary Care Settings
Official Title  Cognitive Therapy for Suicidal Older Men in Primary Care Settings
Brief Summary

This study will assess the effectiveness of cognitive therapy in reducing the incidence of suicide ideation and behavior in older men in a primary care setting.

Detailed Description

Older adult males have the highest suicide rate of any age group in the U.S. Over 70 percent of older suicide victims have been to their primary care physician within a month of their death, many with a depressive illness that was not detected. However, most research concerning treatments for suicide ideation and behavior has focused on adolescents and young adults. Very few treatments have been developed to reduce suicide ideation and behavior in men aged 60 and above. This study will assess the effectiveness of specialized cognitive therapy versus typical treatment in treating older men with suicide ideation.

Participants in this two-year, single-blind study will be randomly assigned to receive either cognitive therapy combined with enriched care or enriched care alone. Participants will be identified in primary care settings as having experienced suicide ideation in the past month. Cognitive therapy will be provided by Ph.D.-level therapists and will be geared specifically toward older men with suicidal tendencies. The enriched care condition will consist of the usual care that individuals receive for suicide prevention, plus assessment and referral services provided by independent evaluators and study case managers. All participants will be assessed pre-treatment to attain baseline measures of suicide ideation, hopelessness, and depression. Study visits will occur at baseline and Months 1, 3, 6, 12, 18, and 24 to assess suicide ideation. Self-report and clinician-administered measures will be used to assess participants' progress.

Study Phase Phase I
Study Type  Interventional
Study Design  Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Primary Outcome Measure  Suicidal Ideation; measured at Months 1, 3, 6, 12, 18, and 24
Secondary Outcome Measure  Depression; measured at Months 1, 3, 6, 12, 18, and 24
Hopelessness; measured at Months 1, 3, 6, 12, 18, and 24
Perceived Social Support; measured at Months 1, 3, 6, 12, 18, and 24
Condition  Suicide, Attempted
Intervention  Behavioral: Cognitive Therapy
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  48
Start Date  May 2005
Completion Date
Eligibility Criteria 

Inclusion Criteria:

  • Currently experiencing death ideation or suicidal ideation (total score greater than 0 on the Scale for Suicide Ideation)
  • English-speaking
  • Lives within the area served by the research unit
  • Able to provide at least 2 verifiable contacts (typically family members)

Exclusion Criteria:

  • Requires priority treatment for an acute, unstable, or severe Axis III disorder (e.g., dementia)
  • Requires priority treatment for another debilitating problem (e.g., severe alcohol or drug dependence, mania, severe anorexia)
  • Suffers from a psychotic disorder or psychotic thought processes
  • Exhibits self-mutilating behavior without any intent to commit suicide (e.g., burning oneself with a cigarette)
Gender Male
Ages 60 Years and older
Accepts Healthy Volunteers No
Contacts ††
Contact: Gregory K. Brown, PhD     215-898-4104     gregbrow@mail.med.upenn.edu    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00149773
Organization ID P20 MH71905-01
Secondary IDs †† 802223, DSIR 83-ATP
Study Sponsor  National Institute of Mental Health (NIMH)
Collaborators ††
Investigators 
Principal Investigator:     Aaron T. Beck, MD     University of Pennsylvania    
Principal Investigator:     Gregory K. Brown, PhD     University of Pennsylvania    
Information Provided By National Institute of Mental Health (NIMH)
Verification Date June 2006
First Received Date  September 6, 2005
Last Updated Date January 29, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers